Abstract:Objective To discuss the differences in curative effect and safety between insulin glulisine with insulin glargine and insulin aspart with insulin glargine when treating islet beta cell dysfunction in type 2 diabetes.Methods Sixty-eight type 2 diabetes patients with islet beta cell dysfunction who were hospitalized in the Endocrinology Department of the Second Hospital of Jilin University or received outpatient treatment from December 2015 to June 2016 were selected and randomly divided into the experimental group administered with a glucose-lowering treatment through subcutaneous injection of insulin glulisine with insulin glargine and the control group administered with a glucose-lowering treatment through subcutaneous injection of insulin aspart with insulin glargine.All the cases received publicity and education of diabetes,and diet and exercise management.The changes of blood glucose of fasting,before meal,2 hours after three meals and bedtime,daily insulin dose,glycosylated hemoglobin (HbA1c) and frequency of hypoglycemia were compared before and after treatment.Results Through three months of follow-up,there was a significant decline in both groups in terms of glucose of fasting,before meal,2 hours after three meals and bedtime,and HbA1c compared with the counterparts before treatment (P＜ 0.01).There was no significant difference in daily insulin dose to target level to control the glucose between the groups (P＞ 0.05).The control group was better than the experimental group in terms of glucose control before meal and during nighttime (P ＜ 0.05).The experimental group was better than the control group in terms of controlling the glucose 2 hours after meal (P ＜ 0.05).There was no significant difference in controlling the glycosylated hemoglobin between the groups (P ＞ 0.05).The experimental group evidently had a lower frequency of hypoglycemia than the control group did,which was statistically significant (P＜ 0.05).Conclusions Insulin glulisine combined with insulin glargine is better in controlling the glucose of patients with islet beta cell dysfunction in type 2 diabetes than insulin aspart combined with insulin glargine,performing a better tolerance and a lower frequency of hypoglycemia,lowering the glucose fluctuation and reducing or delaying the occurrence of various acute and chronic complications of diabetes.

Curvative Effect of Insulin Intensive Treatment Used in Type 2 Diabetes Patients

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Efficacy Observation of the Intensivetherapy of Short-acting Insulin for 32 Patients with Type 2 Diabetes

Observation of curative effect on Insulin Aspartate in the treatment of newly diagnosed type 2 diabetes mellitus

In Combination with Insulin Detemir,Insulin Aspart Efficacy Evaluation of Intensive Treatment of Type 2 Diabetes

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.

Efficacy of Intensive Insulin Therapy and Multiple Insulin Injections on Early-Onset Type 2 Diabetes

Clinical Observation on Starting Insulin after Failure of Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus

The effects of short-term insulin intensive treatment on islet B cell function and insulin sensitivity in newly-diagnosed Type 2 Diabetic Patients

Effect of short-term intensive insulin pump treatment on related indexes of patients with early type 2 diabetes mellitus

The Clinical Outcome of Early Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes

[Influencing Factors for the Curative Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Newly Diagnosed Type 2 Diabetes].

[The Effects of Early Intensive Therapy on Islet Beta Cell Function and Long-Term Glycemia Control in Newly Diagnosed Type 2 Diabetic Patients with Different Fasting Plasma Glucose Levels.].

Effect of intensive insulin therapy on serum inflammatory factors in newly onset diabetic patients

Comparison of efficacy and safety of insulin glulisine and insulin aspart in treatment of islet beta cell dysfunction in type 2 diabetes patients

Comparison of the efficacy between short term intensive therapy by insulin pump and multiple subcutaneous insulin injections

Effect of regular intensive therapy with insulin pump on beta cell function in newly diagnosed type 2 diabetes mellitus

Effect of Intensive Insulin Therapy on Vascular Endothelial Function in Newly Diagnosed Type 2 Diabetes Patients

Effect of different short-term intensive treatment methods on plasminogen activator inhibitor-1 in newly diagnosed type 2 diabetic patients

Therapeutic Comparison on Insulia Aspart 30 and Novolin 30R in the Treatment of Type Two Diabetes Mellitus after Failure to Oral Hypoglycemic Agents

Effect of insulin pump infusion therapy on beta cell of islet function in newly diagnosed type 2 diabetes